MEGAN BOYLE: Open Payments
NPI 1386298040 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$309 in 13 payments from 5 companies in 2025. Trend: 2023 $90 · 2024 $429 · 2025 $309
Food & beverage: $309
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $208 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
Products named: VRAYLAR, UZEDY, REXULTI, INVEGA SUSTENNA, ARISTADA.
Industry payments across PA — which companies pay providers there.
